Corbus Pharmaceuticals logo
Corbus Pharmaceuticals
CRBP | NASDAQ
Chart Builder DCF Calculator
$3.38
-$0.01 (-0.29%)
At close: Nov 16, 2026, 4:00 PM ET
$3.19
-$0.19 (-5.62%)
After-hours: Nov 16, 2026, 7:39 PM ET

Corbus Pharmaceuticals Company Profile

Company profile explained

Company Profile

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.

Key Executives

Name Position
Yuval Cohen Chief Executive Officer & Director
Ian Hodgson Chief Operating Officer
Sean F. Moran Chief Financial Officer
Christina Bertsch Vice President of Human Resources
G. Scott Goeken General Counsel & Corporate Secretary
Leonardo Viana Nicacio Chief Medical Officer
Nishant C. Saxena Chief Business Officer

Latest SEC Filings

Date Type Title
Oct 29, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 15, 2026 8-K Current Report
Sep 30, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Sep 15, 2026 4 Filing
Sep 14, 2026 8-K Current Report
Aug 17, 2026 4 Filing
Aug 12, 2026 4 Filing
Aug 10, 2026 4 Filing
Aug 10, 2026 4 Filing
Aug 07, 2026 424B5 Filing
View All SEC Filings ➞
Corbus Pharmaceuticals
Corbus Pharmaceuticals logo
Country United States
IPO Date Oct 27, 2014
Industry Biotechnology
Sector Healthcare
Employees 36
CEO Yuval Cohen

Contact Details

500 River Ridge Drive Norwood, Massachusetts 02062 United States

Stock Details

Ticker Symbol CRBP
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001595097
CUSIP Number 21833P301
ISIN Number US21833P3010
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.